Logo

Quark, Fujisawa Ink Drug-Discovery Deal for Stroke

Aug 06, 2002

NEW YORK, Aug. 6 - Quark Biotech and Japanese pharma firm Fujisawa today said they have penned a drug-discovery collaboration to treat stroke.

Terms of the deal call for Fujisawa to fund the research program, in which Quark will use its high-throughput technology.

Fujisawa will have worldwide exclusive rights on any resulting products, and Quark has an option to co-market certain products in the United States and the European Community.

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.